nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibiotic resistance in the USA
|
Spencer, Kate |
|
2014 |
14 |
11 |
p. 1053- 1 p. |
artikel |
2 |
Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults
|
Harris, Patrick N A |
|
2014 |
14 |
11 |
p. 1043- 1 p. |
artikel |
3 |
Autochthonous dengue emphasises the threat of arbovirosis in Europe
|
Schaffner, Francis |
|
2014 |
14 |
11 |
p. 1044- 1 p. |
artikel |
4 |
Corrections
|
|
|
2014 |
14 |
11 |
p. 1040- 1 p. |
artikel |
5 |
Corrections
|
|
|
2014 |
14 |
11 |
p. 1040- 1 p. |
artikel |
6 |
Corrections
|
|
|
2014 |
14 |
11 |
p. 1040- 1 p. |
artikel |
7 |
Digital surveillance for enhanced detection and response to outbreaks
|
Anema, Aranka |
|
2014 |
14 |
11 |
p. 1035-1037 3 p. |
artikel |
8 |
Ebola and compliance with infection prevention measures in Nigeria
|
Yusuf, Ibrahim |
|
2014 |
14 |
11 |
p. 1045-1046 2 p. |
artikel |
9 |
Ebola in west Africa
|
Trad, Mohamad-Ali |
|
2014 |
14 |
11 |
p. 1045- 1 p. |
artikel |
10 |
Ebola in west Africa: from disease outbreak to humanitarian crisis
|
Piot, Peter |
|
2014 |
14 |
11 |
p. 1034-1035 2 p. |
artikel |
11 |
Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study
|
Groome, Michelle J |
|
2014 |
14 |
11 |
p. 1096-1104 9 p. |
artikel |
12 |
Emergence of a hypervirulent neonatal pathogen
|
Manning, Shannon D |
|
2014 |
14 |
11 |
p. 1028-1030 3 p. |
artikel |
13 |
Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options
|
Zumla, Alimuddin |
|
2014 |
14 |
11 |
p. 1136-1149 14 p. |
artikel |
14 |
Emerging viral respiratory tract infections—environmental risk factors and transmission
|
Gautret, Philippe |
|
2014 |
14 |
11 |
p. 1113-1122 10 p. |
artikel |
15 |
Enterovirus D68: the unexpected guest
|
The Lancet Infectious Diseases, |
|
2014 |
14 |
11 |
p. 1023- 1 p. |
artikel |
16 |
Global burden of listeriosis: the tip of the iceberg
|
Leclercq, Alexandre |
|
2014 |
14 |
11 |
p. 1027-1028 2 p. |
artikel |
17 |
Hand, foot, and mouth disease in mainland China
|
Lu, Bin |
|
2014 |
14 |
11 |
p. 1041- 1 p. |
artikel |
18 |
Hand, foot, and mouth disease in mainland China
|
Mao, Qunying |
|
2014 |
14 |
11 |
p. 1041- 1 p. |
artikel |
19 |
Hand, foot, and mouth disease in mainland China
|
Li, Peiqing |
|
2014 |
14 |
11 |
p. 1042- 1 p. |
artikel |
20 |
Hand, foot, and mouth disease in mainland China–Authors' reply
|
Leung, Gabriel M |
|
2014 |
14 |
11 |
p. 1042- 1 p. |
artikel |
21 |
Helminth therapy or elimination: epidemiological, immunological, and clinical considerations
|
Wammes, Linda J |
|
2014 |
14 |
11 |
p. 1150-1162 13 p. |
artikel |
22 |
Hepatitis virus and HIV interactions
|
Milazzo, Laura |
|
2014 |
14 |
11 |
p. 1025-1027 3 p. |
artikel |
23 |
HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010–12: a retrospective observational cohort study
|
Zhang, Fujie |
|
2014 |
14 |
11 |
p. 1065-1072 8 p. |
artikel |
24 |
Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study
|
Bekker, Vincent |
|
2014 |
14 |
11 |
p. 1083-1089 7 p. |
artikel |
25 |
Infectious diseases surveillance update
|
Sekkides, Onisillos |
|
2014 |
14 |
11 |
p. 1051- 1 p. |
artikel |
26 |
Investment in pneumonia and pneumococcal research
|
Head, Michael G |
|
2014 |
14 |
11 |
p. 1037-1038 2 p. |
artikel |
27 |
Mass prophylaxis of tuberculosis through social protection
|
Lönnroth, Knut |
|
2014 |
14 |
11 |
p. 1032-1034 3 p. |
artikel |
28 |
Neglected tropical diseases take hold in the USA
|
Nelson, Roxanne |
|
2014 |
14 |
11 |
p. 1050-1051 2 p. |
artikel |
29 |
Preserving pathogens with pandemic potential
|
Burki, Talha |
|
2014 |
14 |
11 |
p. 1048-1049 2 p. |
artikel |
30 |
Raltegravir and rifampicin in patients with HIV and tuberculosis
|
Klis, Sandor |
|
2014 |
14 |
11 |
p. 1046-1047 2 p. |
artikel |
31 |
Raltegravir and rifampicin in patients with HIV and tuberculosis
|
Bierman, Wouter F W |
|
2014 |
14 |
11 |
p. 1047- 1 p. |
artikel |
32 |
Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects
|
Zumla, Alimuddin |
|
2014 |
14 |
11 |
p. 1123-1135 13 p. |
artikel |
33 |
Research brief
|
Bradbury, Jane |
|
2014 |
14 |
11 |
p. 1052- 1 p. |
artikel |
34 |
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
|
Omrani, Ali S |
|
2014 |
14 |
11 |
p. 1090-1095 6 p. |
artikel |
35 |
Silence is not golden
|
Harrison, Natalie |
|
2014 |
14 |
11 |
p. 1054- 1 p. |
artikel |
36 |
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
|
Baeten, Jared M |
|
2014 |
14 |
11 |
p. 1055-1064 10 p. |
artikel |
37 |
Social protection and tuberculosis control in 21 European countries, 1995–2012: a cross-national statistical modelling analysis
|
Reeves, Aaron |
|
2014 |
14 |
11 |
p. 1105-1112 8 p. |
artikel |
38 |
Sustaining rotavirus vaccination in Africa: measuring vaccine effectiveness
|
Armah, George E |
|
2014 |
14 |
11 |
p. 1031-1032 2 p. |
artikel |
39 |
The Caribbean response to chikungunya
|
Olowokure, Babatunde |
|
2014 |
14 |
11 |
p. 1039-1040 2 p. |
artikel |
40 |
The global burden of listeriosis: a systematic review and meta-analysis
|
de Noordhout, Charline Maertens |
|
2014 |
14 |
11 |
p. 1073-1082 10 p. |
artikel |
41 |
Treating MERS-CoV during an outbreak
|
Coleman, Christopher M |
|
2014 |
14 |
11 |
p. 1030-1031 2 p. |
artikel |
42 |
When is good good enough for HIV-1 prophylaxis?
|
Buchbinder, Susan |
|
2014 |
14 |
11 |
p. 1024-1025 2 p. |
artikel |